Cancer

Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis

Analysis of eligible1 patients from the sepsis Phase II study (NCT# NCT04612413) In accordance with the study protocol, the safety and…

9 months ago

iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium

ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering radiologists in…

9 months ago

ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI

The companies will work together to help save gastroenterologists time by providing real-time integration between ModMed’s gGastro® ASC and Medtronic’s…

9 months ago

Aptevo Therapeutics Provides Pipeline Update

Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now…

9 months ago

Yunu Adds Pediatric Oncologist Dr. Scott Bradfield as Strategic Advisor

Collaboration aims to advance pediatric oncology trial precision with the latest imaging technology.CARY, NC / ACCESSWIRE / April 10, 2024…

9 months ago

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing…

9 months ago

Cantargia Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in a Leading Scientific Journal

LUND, SWEDEN / ACCESSWIRE / April 10, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of…

9 months ago

Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders

Company not implementing a reverse split at this timeTop line results forthcoming for company's phase 3 OnTarget trial of crofelemer…

9 months ago

Emet Surgical Accepted into Innosphere Ventures Life Sciences Incubator Program

DENVER--(BUSINESS WIRE)--Emet Surgical, developers of innovative tools to improve surgery outcomes, today announced its acceptance into the Innosphere Ventures Life…

9 months ago

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

CHICAGO--(BUSINESS WIRE)--#aheadofcancer--CancerIQ is proud to announce that co-founder and CEO Feyi Ayodele was recognized by Modern Healthcare as one of…

9 months ago